Medicine Maker features Aktana’s Alan Kalton

June 22, 2021/Aktana/

Alan Kalton speaks to the Medicine Maker about how different size pharma organizations are handling AI adoption and why using AI to improve the patient experience is a golden opportunity that can’t be missed. Read the full article here.

PM360 Spotlights Advice from Aktana’s Alan Kalton

June 10, 2021/Aktana/

The pandemic introduced new ways of working—and new customer expectations. With many HCPs oversaturated with digital marketing, AI-enabled optimization offers a proven path to personalization. Alan Kalton shares advice for upping your digital game. Read the full article here.

Aktana Expands Leadership Team to Drive Global AI Strategy in Life Sciences

May 26, 2021/Aktana/

One of the UK’s most influential women in tech, Bingqian Gao, will build advanced analytics center of excellence to improve omnichannel customer experience in a digital-first world SAN FRANCISCO, May 26, 2021 (GLOBAL NEWSWIRE) — Aktana, the global leader in intelligent customer engagement for the life sciences industry, announced a strategic investment in its mission […]

5 Lessons Learned from a Pandemic – Annika Hibbits of Novartis with Aktana’s James Anderson & Bruce Carlson for HS&M Magazine

May 11, 2021/Aktana/

After a year of necessity-driven digital transformation, pharma is set to enter its greatest era of personalization and efficiency yet. Annika Hibbits of Novartis joins Aktana’s James Anderson and Bruce Carlson to share their biggest lessons learned from the pandemic with Healthcare Sales & Marketing Magazine. Read the full article here.

Virtual Engagements: What Works, What Doesn’t, and What’s New? Manny Triggiano for PM360 Magazine

April 20, 2021/Aktana/

As virtual engagements become a fixture of the new omnichannel commercial model, how can pharma improve its approach? Aktana’s Emanuele Triggiano writes about the importance of message continuity, relevance and how companies can use AI to achieve both for PM360 Magazine. Read the full article here.

5 AI Discoveries Generated by COVID-19 – Aktana’s James Anderson and Bruce Carlson for Bio-IT World

April 13, 2021/Aktana/

The pandemic pressure-tested several key commercial shifts that pharma has been talking about for years. James Anderson and Bruce Carlson reflect on what we’ve learned about the future of HCP engagement for Bio-IT world. Read the full article here.

Coruzant Technologies features Aktana’s James Anderson

April 13, 2021/Aktana/

By empowering leaner teams to reach HCPs more efficiently, AI is set to be the great commercial equalizer for emerging and mid-sized pharma. James Anderson breaks down how AI can help SMB organizations thrive in a dynamic market for Coruzant Technologies. Read the full article here.

5 AI Lessons Learned During COVID-19 – James Anderson for MedCity News

April 7, 2021/Aktana/

On the other side of the pandemic lies a new era of innovation for the life sciences industry—especially when it comes to HCP engagement. Aktana’s James Anderson shares five key takeaways for using AI to transform commercial execution with MedCity News. Read the full article here.  

Aktana Delivers Intelligent Engagement Solution to Emerging and Mid-Sized Life Sciences Companies

March 23, 2021/Aktana/

Antares Pharma and other growing innovators leverage new class of AI technology to provide customers with a true omnichannel experience SAN FRANCISCO, CA March 23, 2021 (GLOBE NEWSWIRE) — Aktana, the global leader in intelligent customer engagement for the life sciences industry, announced the release of a dedicated configuration of their AI offering tailored to the […]

COVID & Everything After, Aktana’s Jay Borowiecki speaks to MedAdNews

March 1, 2021/Aktana/

From remote engagement to AI-driven personalization, COVID’s impact on the pharma industry will be felt long after the pandemic subsides. Jay Borowiecki and other industry leaders predict which changes will fade and which will redefine the way we engage with HCPs for MedAdNews. Read the full article here.